In glioblastoma cells, knockdown of galectin-1 impairs the ability of insulin-like growth factor (IGF1) stimulation to elevate cellular PIP3 levels (Perry et al.,2010, AACR 101st annual meeting abstract 301). The gene discussed is IGF1; the disease is glioblastoma.